All Issue

2018 Vol.31, Issue 4

August 2018. pp. 275-282
Abstract


References
1 

Agoff, S.N., T.A. Brentnall, D.A. Crispin, S.L. Taylor, S. Raaka, R.C. Haggitt, M.W. Reed, I.A. Afonina, P.S. Rabinovitch, A.C. Stevens, Z. Feng and M.P. Bronner. 2000. The role of cyclooxygenase-2 in ulcerative colitis-associated neoplasia. Am. J. Pathol. 157(3):737-745.

10.1016/S0002-9440(10)64587-7
2 

Bae, K.H. 2003. Illustrated Book of Health for Longevity. Kyohaksa, Seoul, Korea. p. 426 (in Korean).

3 

Choi, C.H., Y.H. Kim, Y.S. Kim, B.D. Ye, K.M. Lee, B.I. Lee, S.A. Jung, W.H. Kim and H.Y. Lee. 2012. IBD study group of the Korean Association for the Study of Intestinal Diseases: Guidelines for the management of Ulcerative colitis. Korean J. Gastroenterol. 59(2):118-140.

10.4166/kjg.2012.59.2.11822387836
4 

Chuang, W.C., W.C. Lin, S.J. Sheu, S.H. Chiou, H.C. Chang and Y.P. Chen. 1996. A comparative study on commercial samples of the roots of Paeonia vitchii and P. lactiflora. Planta. Med. 62(4):347-351.

10.1055/s-2006-95789917252469
5 

Cooper, H.S., S.N. Murthy, R.S. Shah and D.J. Sedergran. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69(2):238-249.

8350599
6 

Danese, S., M. Sans and C. Fiocchi. 2004. Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3(5):394-400.

10.1016/j.autrev.2004.03.002
7 

Domènech, E. 2006. Inflammatory bowel disease: current therapeutic options. Digestion 73(1):67-76.

10.1159/00008978116498254
8 

Hendel, J. and O.H. Nielsen. 1997. Expression of cyclooxygenase- 2 mRNA in active inflammatory bowel disease. Am. J. Gastroenterol. 92(7):1170-1173.

9219792
9 

Hendrickson, B.A., R. Gokhale and J.H. Cho. 2002. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev. 15(1):79-94.

10.1128/CMR.15.1.79-94.200211781268 PMC118061
10 

Hsieh, C.L., C.Y. Cheng, T.H. Tsai, I.H. Lin, C.H. Liu, S.Y. Chiang, J.G. Lin, C.J. Lao and N.Y. Tang. 2006. Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. J. Ethnopharmacol. 106(2):208-211.

10.1016/j.jep.2005.12.02716458462
11 

Hyams, J.S. 2000. Inflammatory bowel disease. Pediatr. Rev. 21(9):291-295.

10.1542/pir.21-9-29110970450
12 

Ishiguro, K., T. Ando, O. Maeda, M. Hasegawa, K. Kadomatsu, N. Ohmiya, Y. Niwa, R. Xavier and H. Goto. 2006. Paeonol attenuates TNBS-induced colitis by inhibiting NF-B and STAT1 transactivation. Toxicol. Appl. Pharmacol. 217(1): 35-42.

10.1016/j.taap.2006.07.00216928387
13 

Ji, S.T., S.J. Lee, K.E. Lee, Y.T. Son and Y.K. Chung. 2002. Inhibitory effect of extracts from Paeoniae radixon Postprandial Hyperglycemia. J. Korean Soc. Food Sci. Nutr. 31(1):131-135.

10.3746/jkfn.2002.31.1.131
14 

Kawamori, T., C.V. Rao, K. Seibert and B.S. Reddy. 1998. Chemopreventive activity of elecoxib, a specific cyclooxygenase- 2 inhibitor, against colon carcinogenesis. Cancer Res. 58: 409-412.

9458081
15 

Kim, J.H. and E.J. Kim. 2018. Evaluation of anti-oxidative, anti-thrombin, anti-invasive and pro-apoptotic activities of Paeonia japonica. Korean J. Plant Res. 31(1):16-23.

16 

Lee, B., Y.W. Shin, E.A. Bae, S.J. Han, J.S. Kim, S.S. Kang and D.H. Kim. 2008. Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol. Arch. Pharm. Res. 31(4):445-450.

10.1007/s12272-001-1177-618449501
17 

Li, Y., C. de Haar, M. Chen, J. Deuring, M.M. Gerrits, R. Smits, B. Xia, E.J. Kuipers and C.J. van der Woude. 2010. Disease- related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut 59(2):227-235.

10.1136/gut.2009.18417619926618
18 

Lichtenstein, G.R. and P. Rutgeerts. 2010. Importance of mucosal healing in ulcerative colitis. Inflamm. Bowel. Dis. 16(2):338-346.

10.1002/ibd.2099719637362
19 

Lim, K.S., J.K. Park, M.H. Jeong, I.H. Bae, D.S. Park, J.W. Shim, J.H. Kim, H.K. Kim, S.S. Kim, D.S. Sim, Y.J. Hong, J.H. Kim and Y. Ahn. 2018. Anti-inflammatory effect of gallic acid-eluting stent in a Porcine Coronary Restenosis Model. Acta. Cardiol. Sin. 34(3):224-232.

20 

Lyu, Z.K., C.L. Li, Y. Jin, Y.Z. Liu, X. Zhang, F. Zhang, L.N. Ning, E.S. Liang, M. Ma, W. Gao, M.X. Zhang and D.S. Liu. 2017. Paeonol exerts potential activities to inhibit the growth, migration and invasion of human gastric cancer BGC823 cells via downregulating MMP 2 and MMP 9. Mol. Med. Rep. 16(5):7513-7519.

10.3892/mmr.2017.7576
21 

Matuk, R., J. Crawford, M.T. Abreu, S.R. Targan, E.A. Vasiliauskas and K.A. Papadakis. 2004. The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 10(4):352-356.

10.1097/00054725-200407000-00005
22 

Ministry of Food and Drug Safety. 2014. Korean Pharmacopeia (tenth edition) Monographs Part2. Ministry of Food and Drug Safety, Cheongju, Korea. p. 1341.

23 

Murthy, S.N., H.S. Cooper, H. Shim, R.S. Shah, S.A. Ibrahim and D.J. Sedergran. 1993. Treatment of dextran sulfate sodium-induced murine colitis by intracoloniccyclosporin. Dig. Dis. Sci. 38(9):1722-1734.

10.1007/BF013031848359087
24 

Ngan, L.T., M.J. Jang, M.J. Kwon and Y.J. Ahn. 2015. Antiviral activity and possible mechanism of action of constituents identified in Paeonia lactiflora root toward human rhinoviruses. PLoS One 10(4):e0121629.

10.1371/journal.pone.012162925860871PMC4393083
25 

Ogata, H. and T. Hibi. 2003. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharm. Des. 9(14): 1107-1113.

10.2174/138161203345503512769750
26 

Oriental Medicine Pharmacology Textbook Compilation Committee. 2010. Oriental Medicine Pharmacology (third edition). Shinilbooks, Seoul, Korea. pp. 694-700 (in Korean).

27 

Papadakis, K.A. and S.R. Targan. 2000. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 51:289-298.

10.1146/annurev.med.51.1.28910774465
28 

Park, K.K., H.S. Park, Y.H. Cho, H.O. Yang, W.K. Ko, H.S. Ro and Y.E. Lee. 1999. Isolation of hyperlipidemic substancesfrom methanol extract of Paeoniae radix. J. Pharm. Investig. 29: 55-60.

29 

Ro, H.S., W.K. Ko, H.O. Yang, K.K. Park, Y.H. Cho and H.S. Park. 1997. Effect of several solvent extracts from Paeoniae radix on experimental hyperlipidemia in rats. J. Pharm. Investig. 27:145-151.

30 

Roberts, P.J., K. Morgan, R. Miller, J.O. Hunter and S.J. Middleton. 2001. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48(4):468-472.

10.1136/gut.48.4.46811247889PMC1728255
31 

Rogler, G. and T. Andus. 1998. Cytokines in inflammatory bowel disease. World J. Surg. 22(4):382-389.

10.1007/s0026899004019523521
32 

Tsai, H.Y., H.Y. Lin, Y.C. Fong, J.B. Wu, Y.F. Chen, M. Tsuzuki and C.H. Tang. 2008. Paeonol inhibits RANKL- induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway. Eur. J. Pharmacol. 588(1):124-133.

10.1016/j.ejphar.2008.04.02418495114
33 

Vázquez Cisneros, L.C., P. López-Uriarte, A. López-Espinoza, M. Navarro Meza, A.C. Espinoza-Gallardo and M.B. Guzmán Aburto. 2017. Effects of green tea and its epigallocatechin (EGCG) content on body weight and fat mass in humans: a systematic review. Nutr. Hosp. 34(3):731-737.

10.20960/nh.75328627214
34 

Wu, H.K. and S.J. Sheu. 1996. Capillary electrophoretic determination of the constituents of Paeoniae radix. J. Chromatogr. A. 753(1):139-146.

10.1016/S0021-9673(96)00525-0
35 

Zhang, J., W. Dou, E. Zhang, A. Sun, L. Ding, X. Wei, G. Chou, S. Mani and Z. Wang. 2014. Paeoniflorin abrogates DSS- induced colitis via a TLR4-dependent pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 306(1):G27-36.

10.1152/ajpgi.00465.201224232001PMC3920084
36 

Zhong, S.Z., Q.H. Ge, R. Qu, Q. Li and S.P. Ma. 2009. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice. J. Neurol. Sci. 277(1-2): 58-64.

10.1016/j.jns.2008.10.00819007942
Information
  • Publisher :The Plant Resources Society of Korea
  • Publisher(Ko) :한국자원식물학회
  • Journal Title :Korean Journal of Plant Resources
  • Journal Title(Ko) :한국자원식물학회지
  • Volume : 31
  • No :4
  • Pages :275-282
  • Received Date :2018. 01. 31
  • Revised Date :2018. 06. 07
  • Accepted Date : 2018. 06. 11